A carregar...

Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line

AIM: To investigate the effect and mechanism of action of erlotinib, an epidermal growth factor receptor (EGFR) small molecule tyrosine kinase inhibitor (TKI), in the human pancreatic cancer cell line BxPC-3 both in vitro and in vivo. METHODS: In vitro, human pancreatic cancer cell line BxPC-3 was e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lu, Ying-Ying, Jing, Da-Dao, Xu, Ming, Wu, Kai, Wang, Xing-Peng
Formato: Artigo
Idioma:Inglês
Publicado em: The WJG Press and Baishideng 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2744159/
https://ncbi.nlm.nih.gov/pubmed/18803351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.14.5403
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!